TCS Q1 FY27 Results (NSE: TCS)

· Analysis by Alpha Inflection

Signal: Margin pressure

The read

Revenue growth held steady at 13.9% YoY but the operating margin was hit by an exceptional ₹668 Cr legal settlement (CSC case), dragging EBIT margin to 22.66% — down 148bps YoY and 235bps QoQ, marking an inflection point for margins; excluding the one-time charge, core EBIT margin would have been ~24.4% and PAT growth ~9.9% YoY; BFSI and Life Sciences continue to show strong momentum.

TCS Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹72,275 Cr13.93%2.23%
Net profit₹13,420 Cr4.69%
EPS₹36.9
EBIT margin22.66%

Segments

BFSI segment revenue of ₹27,990 Cr (+13.2% YoY) and segment result of ₹7,177 Cr (+15.5% YoY) drove the consolidated growth, contributing 39% of revenue and 39% of segment profit; Manufacturing grew 11.1% YoY to ₹7,110 Cr but its segment result margin slipped to 27.9%; Life Sciences & Healthcare was the fastest-growing segment at +15.7% YoY (₹7,429 Cr) with a strong 24.7% margin, while Consumer Business revenue decelerated to +9.8% YoY (₹11,146 Cr) with margin contraction to 29.7%; Communication, Media & Technology was the weakest with segment result margin at 26.8%, down from 28.1% in Q1FY26.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.